Here are some of the Duke Cancer Institute faculty, researchers, and clinical providers whose work has recently been featured by the media, academic trade publications & journals.
DCI director Michael B. Kastan, MD, PhD, announced a planned reconfiguration of DCI’s NCI-Designated Research Programs and welcomed new research leaders.
Led by a team from Duke, an international group of 56 researchers has found new mutations identifying potential treatments and new hope for patients w...
The Leukemia and Lymphoma Society (LLS), the world's largest voluntary health agency dedicated to blood cancer, recently awarded grants to two Duke Ca...
Lymphoma is the most common blood cancer, but the diagnosis belies a wildly diverse and little understood genetic foundation for the disease that hamp...
Duke Cancer Institute researchers are attending the American Society of Hematology’s (ASH) 59th Annual Meeting & Exposition in Atlanta this week.Here ...